Canadian Tire Corporation to purchase Helly Hansen for $985 million
Category: #retail  By Pankaj Singh  Date: 2018-05-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

Canadian Tire Corporation to purchase Helly Hansen for $985 million

Canadian Tire Corporation Limited has reportedly announced that it has entered into an agreement to buy Helly Hansen – a leading workwear and sportswear producer based in Oslo, Norway.

Through Mark's and FGL, Canadian Tire Corporation has been dealing with Helly Hansen for long, the firm being one of its largest customers. This acquisition is expected to strengthen the workwear and outdoor categories that are core to Canadian Tire Corporation’s retail banners. It also reinforces the company’s core businesses across several banners, expanding its brand offerings in Canada as well as overseas.

The President and CEO of Canadian Tire Corporation, Stephen Wetmore said that Helly Hansen had been an excellent fit with the company for more than 10 years and the acquisition will considerably strengthen the company’s assortment across all its banners. He added that with Helly Hansen’s recognition as a trusted global brand combined with the capabilities of Canadian Tire Corporation, opportunities will be immense for both the companies.

Reliable resources quote Paul Stoneham, CEO, Helly Hansen to have said that the platform that Canadian Tire Corporation can provide Helly Hansen can accelerate the growth trajectory of the company.

Founded in 1877, Helly Hansen is regulated by the Ontario Teachers' Pension Plan and is known for the professional grade gear it produces. Helly Hansen is also a leader in designing high quality and innovative products for technical performance in the harshest outdoor conditions. The company designs and delivers products like sailing, mountaineering, skiing, rain gear and workwear for outdoor enthusiasts and professionals across the world. Having retail and wholesale distribution capabilities across 40 countries, Helly Hansen is a celebrated brand all over the world.

The purchase agreement has been finalized at $985 million with an assumption of approximately $50 million of operating debt. The acquisition is expected to be finalized in the third quarter of 2018.



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...